Company intelligence / Profile preview

Aidoc

New York, New York, United Statesaidoc.com ↗

Ownership: Private
Development stage: Commercial

Overview

Aidoc’s clinical AI platform has demonstrated significant improvements in patient management outcomes. For example, at Yale New Haven Hospital, the use of Aidoc's solution nearly doubled clinic follow-up volume for aortic aneurysm patients, reduced time to intervention from 270 days to 58 days, increased interventions by 14%, and reduced aneurysm rupture rate by 62%. The company has over 17 FDA-cleared algorithms—the most in its category—and its solutions are deployed at more than 1,000 medical centers worldwide.

Therapeutic areas: OtherCardiovascularNeurology
Modalities: Device
Industry: Medical Imaging

Partnerships

Asklepios Kliniken Group (Germany)University Hospitals Health System (Ohio)Yale New Haven Hospital

Beyond the preview

Go deeper on Aidoc.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Aidoc.

Explore the full profile